LQR House arrives at its May 21 earnings date on a sharp week — up 18% in five sessions to $1.03 — but the fundamentals underneath that move are complicated.
Q1 results released Thursday after the close showed revenue of $222,683, down nearly 48% year-over-year from $429,340. The loss per share narrowed dramatically to $(0.04) from $(3.85) a year earlier, reflecting how much the share count has grown rather than an operational turnaround. Full-year 2025 figures from March told a similar story: revenue fell to $1.56 million from $2.5 million, while net loss widened to $25.5 million. The revenue trajectory is clearly negative. The EPS improvement comes largely from the denominator, not the numerator.
The borrow market has been paying attention to the price action. Cost to borrow climbed to 8.52% by May 14 — up 35% over the week — after drifting as low as 5.2% in late April. That said, availability remains wide open: only about a third of the lending pool is in use, a long way from the 52-week high of 99.4% utilisation recorded earlier in the year. Short interest, meanwhile, is modest at roughly 1.5% of the free float and has been drifting lower over the past month, down nearly 14% from early April levels. The borrow-cost spike looks driven by the price rally rather than any fresh directional conviction from short sellers — positioning here is thin, not charged.
The ownership picture tilts heavily towards insiders. President Yilin Lu purchased 2 million shares at $0.90 in December 2025, a $1.8 million outlay that now represents over 9% of the company and is sitting on a modest gain at current prices. No institutional names of scale appear on the register — Vanguard holds just 13,000 shares. Geode added 25,000 shares as of February. The institutional base is effectively absent, meaning price discovery is dominated by a handful of concentrated holders and retail-driven flows.
The ORTEX short score has been creeping higher this week, reaching 45.1 on May 14 from 43.4 on May 11. It remains in the mid-range of its scale and does not point to a particularly stressed setup. The factor scores are similarly unremarkable — a short score rank of 29 and a days-to-cover rank of 26, both in the lower third of the universe. Nothing in the positioning data suggests an aggressive short thesis being built.
The next confirmed earnings event is scheduled for May 21. The last three earnings releases produced a day-one move of +1.2%, then -2.0%, then -6.8% — a pattern that skews negative on release days, though with no consistent follow-through over five sessions. With Q1 revenue already published and largely absorbed by the market on May 15, attention on May 21 is likely to focus on any forward guidance, the Hangzhou GSY Biotechnology wellness-beverage partnership announced on May 6, and whether management can outline a path back toward revenue growth.
See the live data behind this article on ORTEX.
Open YHC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
